Public Affairs & Advocacy
Ignite passion. Influence minds. Inspire action.
We understand the important role advocates play in shaping policy, changing reputation, promoting ideas and expanding the influence of organizations. Stratacomm helps clients harness the power of advocacy to achieve legislative, regulatory and image-improvement victories by combining in-depth industry knowledge and seasoned political instincts, with the talent and experience of our world-class counselors.
EXPERTISE
We run our public affairs and advocacy programs much like an election campaign, leveraging cutting-edge research with innovative outreach strategies to deliver the right message through the right channels to the right people. Elements of these public affairs campaigns can include:
- Campaign Strategy & Management – Conducting opinion research, creating a winning plan and providing expert oversight of program execution and evaluation
- Coalition Building & Grassroots – Organizing and activating credible allies to expand and amplify your impact
- Online Advocacy – Harnessing websites, social networks and other digital tools to educate, build communities and encourage action
- Thought Leadership Tours – Raising visibility and expanding contacts through high-profile events, exhibits, speeches and face-to-face interaction
- Media Outreach & Online Buzz – Creating conversations and telling your story in print, online, via radio and on TV
- Issue Advertising – Producing and placing creative ads that cut through the clutter
GLOBAL REACH AND RELATIONSHIPS
By accessing the network of our parent company, Fleishman-Hillard, Stratacomm’s reach expands far beyond Washington to other key political capitals, including Sacramento, Ottawa, Brussels, London, Tokyo and Beijing. We also regularly tap the unparalleled insight and relationships of the Fleishman-Hillard International Advisory Board, which is comprised of former government leaders like Andy Card (former White House Chief of Staff), Newt Gingrich (former Speaker of the House), Mickey Kantor (former Commerce Secretary and U.S. Trade Representative) and Dr. David Kessler (former Commissioner of the FDA).

